XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock-based compensation cost
Total estimated stock-based compensation expense for employees and non-employees, related to all of the Company's stock-based awards, was comprised as follows:


Three Months Ended

March 31,

2018

2017

 (in thousands)
Cost of revenue
$
18

 
$
(85
)
Selling and marketing
25

 
36

Research and development
30

 
57

General and administrative
150

 
378

Total stock-based compensation
$
223

 
$
386
Stock activity and total number of shares available for grant
The following table presents the stock activity and the total number of shares available for grant as of March 31, 2018:
 
(in thousands)
Balance at December 31, 2017
387

Options granted
(53
)
Restricted Stock granted
—

Forfeited/Expired shares added back
92

Balance at March 31, 2018
426
Stock option activity
 
Options Outstanding
 
Number of Shares Underlying Outstanding Options
 
Weighted-Average Exercise Price
 
Weighted-Average Remaining Contractual Term
 
Aggregate Intrinsic Value
 
 
 
 
 
 (In years)
 
 
Outstanding at December 31, 2017
1,740,082

 
$
6.20

 
6.64
 
$
6

Granted
52,850

 
1.80

 
 
 
 
Exercised
—

 
—

 
 
 
 
Forfeited
(92,326
)
 
8.20

 
 
 
 
Outstanding at March 31, 2018
1,700,606

 
$
5.95

 
6.85
 
$
114,614

Vested and expected to vest at March 31, 2018
1,651,269

 
$
6.12

 
6.78
 
$
106,578

Exercisable at March 31, 2018
1,012,928

 
$
7.56

 
5.50
 
$
—
Schedule of weighted-average assumptions
The following are the assumptions for options granted during the three months ended March 31, 2018.
Expected term (in years)
6.1
Risk-free interest rate
2.3% - 2.7%
Expected volatility
38.6% - 38.8%
Dividend rate
0%
Restricted stock awards  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock option activity
 
Shares
 
Weighted Average Grant Date Fair Value Per Share
Nonvested restricted stock at December 31, 2017
41,867

 
3.84

Granted
—

 
—

Vested
(200
)
 
63.72

Nonvested restricted stock at March 31, 2018
41,667

 
3.56